Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1 <i>H</i> )-quinoline- <i>O</i> -carbamate derivatives as AChE/MAO-B dual inhibitors for the treatment of Alzheimer's disease
- DOI
- 10.1039/d5md01138h
- Published
- 2026
- Container
- RSC Medicinal Chemistry
- Publisher
- Royal Society of Chemistry (RSC)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1039/d5md01138h,
title = {Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1
<i>H</i>
)-quinoline-
<i>O</i>
-carbamate derivatives as AChE/MAO-B dual inhibitors for the treatment of Alzheimer's disease},
author = {Wenling Fu and Keren Wang and Hongsong Chen and Taoyi Liu and Xiaojuan Liu and Qishun Jin and Zhenghuai Tan and Wu Dong and Wenmin Liu and Zhipei Sang},
year = {2026},
journal = {RSC Medicinal Chemistry},
doi = {10.1039/d5md01138h},
url = {https://doi.org/10.1039/d5md01138h}
}RIS
TY - JOUR
TI - Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1
<i>H</i>
)-quinoline-
<i>O</i>
-carbamate derivatives as AChE/MAO-B dual inhibitors for the treatment of Alzheimer's disease
AU - Wenling Fu
AU - Keren Wang
AU - Hongsong Chen
AU - Taoyi Liu
AU - Xiaojuan Liu
AU - Qishun Jin
AU - Zhenghuai Tan
AU - Wu Dong
AU - Wenmin Liu
AU - Zhipei Sang
PY - 2026
JO - RSC Medicinal Chemistry
DO - 10.1039/d5md01138h
UR - https://doi.org/10.1039/d5md01138h
ER - APA
Fu, W., Wang, K., Chen, H., Liu, T., Liu, X., Jin, Q., Tan, Z., Dong, W., Liu, W., & Sang, Z. (2026). Design, synthesis and biological evaluation of novel 3,4-dihydro-2(1 <i>H</i> )-quinoline- <i>O</i> -carbamate derivatives as AChE/MAO-B dual inhibitors for the treatment of Alzheimer's disease. RSC Medicinal Chemistry. https://doi.org/10.1039/d5md01138h
Source records
- crossref · retrieved 2026-09-26T00:26:50.560Z